About VEA Impex
VEA Impex is a company based in Mumbai (India) founded in 2014. VEA Impex offers products and services including Pharmaceutical Medicines and Veterinary Products.
- Headquarter Mumbai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook Instagram
- Legal Name Vea Impex (I) Pvt Ltd
- Date of Incorporation 17 Jun, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹96.93 Cr
FY 2025 · +16% YoY
- Net Profit₹8.40 Cr
FY 2025 · 9% margin
- EBITDA₹11.51 Cr
FY 2025 · 12% margin
Associated legal entities of VEA Impex
VEA Impex operates through Vea Impex (I) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vea Impex (I) Private Limited CIN U51909MH2019PTC326863 | Active | 17 Jun 2019 | Mumbai, Maharashtra | ₹96.9 Cr | 20 | 5 | View details |
Products & Services of VEA Impex
VEA Impex offers a comprehensive portfolio of products and services, including Pharmaceutical Medicines and Veterinary Products.
A variety of pharmaceutical medicines is exported for healthcare purposes, including antibiotics and anti-virals, which are distributed globally.
Veterinary medicines and supplies are provided for animal care, encompassing vaccines and grooming products that support global veterinary needs.
Board of directors of Vea Impex (I) Private Limited (VEA Impex)
Vea Impex (I) Private Limited is the primary company behind VEA Impex. The board of Vea Impex (I) Private Limited currently have 5 directors; the longest-serving is Manthan Shah Rohit, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manthan Shah Rohit DIN 03012868 | Director | 17 Jun 2019 | 7 yrs 3 mo | Vea Impex (I) Private Limited |
| Manan Harish Shah DIN 08436847 | Director | 17 Jun 2019 | 7 yrs 3 mo | Vea Impex (I) Private Limited |
| Yash Hemantbhai Shah DIN 08279243 | Director | 17 Jun 2019 | 7 yrs 3 mo | Vea Impex (I) Private Limited |
| Sandeep Ghatalia Harshad DIN 03061261 | Director | 17 Jun 2019 | 7 yrs 3 mo | Vea Impex (I) Private Limited |
| Ruchi Manthan Shah DIN 07200619 | Director | 30 Sep 2025 | 1 yr | Vea Impex (I) Private Limited |
Financials of VEA Impex
Figures of Vea Impex (I) Private Limited, the primary company behind VEA Impex, for FY 2025. Revenue was ₹96.93 Cr (+16% year on year). Net profit was ₹8.40 Cr (9% margin). EBITDA was ₹11.51 Cr (12% margin). Revenue has grown at a compounded annual rate of +43% over three years and +77% over five years.
- ₹96.93 CrRevenue · FY 2025 · +16% YoY
- ₹8.40 CrNet profit · 9% margin
- ₹11.51 CrEBITDA · 12% margin
- ₹0.05 CrPaid-up capital
- 20Employees (provident fund records)
- +43%Revenue CAGR, 3 years
- +77%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vea Impex (I) Private Limited are on its company page.
Detailed financial statements for VEA Impex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to VEA Impex
10 companies that operate in the same segment as VEA Impex (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VEA Impex
VEA Impex was founded in 2014.
VEA Impex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind VEA Impex, Vea Impex (I) Private Limited, reported revenue of ₹96.93 Cr for FY 2025, up 16% year on year.
VEA Impex is recognized as a leading exporter of pharmaceutical products, where a wide array of medicines and supplies is offered to healthcare providers worldwide. Products such as prescription drugs, generic medicines, and veterinary items are sourced from reputable manufacturers and distributed through reliable channels. Services including cold chain shipment and third-party manufacturing are provided to ensure timely delivery and quality maintenance. Ethical standards are upheld in all operations, fostering partnerships based on trust and transparency, while access to high-quality products is prioritized for global markets.
VEA Impex offers Pharmaceutical Medicines and Veterinary Products.
VEA Impex operates through Vea Impex (I) Private Limited.
The legal entities of VEA Impex currently have 5 directors, including Manthan Shah Rohit, Manan Harish Shah, Yash Hemantbhai Shah and others.